© 2022 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
July 03, 2021
Oncoloytic viruses are an emerging class of cancer therapeutics that may provide a new strategy against malignant tumors.
April 05, 2021
Research on combination therapies involving human papillomavirus-targeted vaccines and immunotherapies continues to expand in phase 2 and 3 trials in patients with head and neck squamous cell carcinoma.